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brain parenchyma (14.58 ± 1.29 μg/g) in conjunction with re-
duced GSH and elevated MDA levels (5.86 ± 0.31 mmol/mg 
and 63.57 ± 5.42 nmol/mg, respectively). Treatment with 
α-tocopherol significantly lowered brain edema formation 
and reduced EB leakage compared with the control group
(p < 0.001, 80.1 ± 0.32% and 6.66 ± 0.87 μg/g, respectively). 
Meanwhile, treatment with α-tocopherol retained tissue
GSH levels and led to a lower MDA level (p < 0.01, 10.17 ±
0.83 mmol/mg, and p < 0.001, 26.84 ± 4.79 nmol/mg, respec-
tively).  Conclusion: Treatment with α-tocopherol reduced 
ischemic edema formation and produced protective effects 
on BBB function following ischemic stroke occurrence. This 
effect could be through increasing antioxidant activity. 
 © 2016 S. Karger AG, Basel 
 Introduction 
 Brain edema is an abnormal accumulation of fluid in 
the brain parenchyma, and is a dangerous complication 
of stroke as it worsens the primary ischemic injury of the 
brain  [1] . Prevention of brain edema formation may re-
duce mortality rates in ischemic stroke. Ischemic brain 
edema happens in 2 phases: cytotoxic edema, which de-
velops within the first minutes to hours following ische-
mia, and vasogenic edema, which is permanent and takes 
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 Abstract 
 Objective: This study was conducted to examine the neuro-
protective effects of α-tocopherol against edema formation 
and disruption of the blood-brain barrier (BBB) following 
transient focal cerebral ischemia in rats.  Materials and Meth-
ods: Ninety-six male Sprague-Dawley rats were divided into 
3 major groups (n = 32 in each), namely the sham, and control 
and α-tocopherol-treated (30 mg/kg) ischemic groups. Tran-
sient focal cerebral ischemia (90 min) was induced by occlu-
sion of the left middle cerebral artery. At the end of the 24-
hour reperfusion period, the animals were randomly selected 
and used for 4 investigations (n = 8) in each of the 3 main 
groups: (a) assessment of neurological score and measure-
ment of infarct size, (b) detection of brain edema formation 
by the wet/dry method, (c) evaluation of BBB permeability 
using the Evans blue (EB) extravasation technique, and (d) as-
sessment of the malondialdehyde (MDA) and reduced gluta-
thione (GSH) concentrations using high-performance liquid 
chromatography methods.  Results: Induction of cerebral 
ischemia in the control group produced extensive brain ede-
ma (brain water content 83.8 ± 0.11%) and EB leakage into 
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hours to days to occur  [2] . Vasogenic edema is character-
ized by an enlarged extracellular volume due to damage 
to the brain capillaries and leakage of plasma proteins 
such as albumin  [3] . Vasogenic edema increases the risk 
for hemorrhage from impaired vessels  [4] and cerebral 
herniation  [2] . 
 Oxidative stress has been shown to be involved in is-
chemia/reperfusion neuronal injury  [5] . Reactive oxygen 
species (ROS) generated during cerebral ischemia and re-
duction of the brain antioxidant capacity are the most 
important causes of ischemic neuronal damage  [6] . In-
cremental ROS production causes damage to lipid mem-
branes and nucleic acids, and may lead to cell death. Gen-
eration of the ROS is further increased by reperfusion
because an abrupt return of glucose and oxygen to the 
neurons causes free radical production at higher levels 
 [7] . Strategies based on antioxidant supplementation 
have been shown to produce protective effects against 
brain injury in experimental models  [8] . α-Tocopherol, 
as a potent antioxidant, is the most important form of vi-
tamin E. It has been reported that exogenous administra-
tion of α-tocopherol produces neuroprotective effects 
against cerebral ischemic injury, most probably by a re-
duction of ROS formation and the inhibition of inflam-
mation and apoptosis  [9, 10] . However, there are no data 
about the effects of α-tocopherol on vasogenic brain ede-
ma formation and blood-brain barrier (BBB) disruption 
following ischemia. Therefore, this study was conducted 
to investigate the effects of α-tocopherol supplementa-
tion on ischemic brain edema formation, BBB permeabil-
ity and oxidative stress biomarkers in the rat brain follow-
ing transient focal cerebral ischemia. 
 Materials and Methods 
 Animals 
 Ninety-six male normotensive Sprague Dawley rats (280–320 
g) were obtained from the central animal house facility of Ardabil 
Medical Sciences University, Ardabil, Iran. All protocols of the 
study were approved by the Institutional Animal Ethics Commit-
tee of Ardabil Medical Sciences University, which follows the NIH 
guidelines for the care and use of animals. The animals were food 
fasted overnight but had access to water. Anesthesia was per-
formed intraperitoneally by injecting chloral hydrate (400 mg/kg). 
Body temperatures were maintained at 37 ± 0.5   °   C with a heating 
feedback control system.
 Induction of Transient Focal Cerebral Ischemia 
 Ninety-minute middle cerebral artery occlusion (MCAO) and 
24-hour reperfusion of the left cerebral hemisphere were induced 
by the intraluminal filament method  [11, 12] . Regional cerebral 
blood flow (rCBF) was recorded from the cerebral cortex of the left 
hemisphere in the supply region of the middle cerebral artery 
(MCA) by means of a laser Doppler flowmeter pencil probe 
(MNP100; AD Instruments, Bella Vista, Australia). Baseline rCBF 
values measured before MCAO were defined as 100%. MCAO was 
accepted as a decrease in rCBF to lower than 20% of the baseline 
value.
 Experimental Protocol 
 Experiments were performed on 3 main groups of randomly 
divided animals:
 Group 1 (sham, n = 32), rats underwent surgery at the neck
region without being exposed to MCAO and received the vehicle 
(1 ml/kg) and 1% dimethyl sulfoxide intraperitoneally at the end 
of surgery. 
 Group 2 (control ischemic; n = 32), ischemia was induced by 
90 min of MCAO followed by 24 h of reperfusion and the animals 
were treated with vehicle at the beginning of the reperfusion time. 
 Group 3 (α-tocopherol-treated ischemic rats; n = 32), ischemia 
was induced and reperfusion performed as per group 2, after which 
α-tocopherol (30 mg/kg; LKT laboratories, St. Paul, MN, USA) was 
given at the beginning of the reperfusion time, as described previ-
ously  [8] . 
 Four sets of animals (n = 8) were studied in each main group. 
The first set was used for evaluation of the neurological score and 
measurement of infarct size. The second set of animals was select-
ed to determine brain edema formation. Detection of BBB perme-
ability was the objective for the third set of rats. The fourth set was 
used for assessment of the oxidative stress biomarkers (glutathi-
one, GSH, and malondialdehyde, MDA). Rats that had incomplete 
MCAO and did not show rCBF <20% of baseline (n = 1 in group 
3) or died within 24 h after ischemia (n = 1 in group 2) were ex-
cluded from the study (n = 2).
 Assessment of Neurological Outcome  
 A blinded observer assessed the neurological deficit 24 h after 
surgery. A 5-point scale of the neurological deficit score (NDS) test 
was carried out as described by Panahpour and Dehghani  [13] . 
Briefly, the rats were graded as follows: normal motor function, 1; 
flexion of the contralateral torso or forelimb upon lifting of the tail, 
2; circling to the contralateral side of the occlusion, 3; loss of right-
ing reflex and decreased resistance to lateral push, 4, and no spon-
taneous motor activity, 5.
 Measurement of the Cerebral Infarct Size 
 Sections of the brain were cut into six 2-mm-thick slices in the 
coronal plane with a brain matrix. The slices were then stained 
with a 2% solution of 2,3,5-triphenyltetrazolium chloride (TTC; 
Molekula, Newcastle upon Tyne, UK) at 37  °  C for 15 min and fixed 
in buffered formalin. Images of the stained sections were obtained 
and the infarction areas were quantified using Scion image ana-
lyzer software  [13] .
 Detection of Brain Edema Formation 
 Ischemic brain edema was assessed using the dry/wet method 
 [14] . Each hemisphere of the brain was placed in a distinct pre-
weighed dish to measure its wet weight (WW). Then the dish and 
the tissues were placed in a 110   °  C oven for 24 h to find the tissue 
dry weight (DW). The absolute brain water content (WC) of each 
hemisphere (%) was calculated using the following equation:
 WC (%) = [(WW – DW)/WW] × 100.
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 Assessment of BBB Permeability 
 BBB permeability was estimated with the Evans blue (EB) ex-
travasation technique  [15] . The EB infusion (i.v. 1 ml/kg of 2% EB 
solution in saline) was started 30 min after surgery and continued 
for 5 min. After 24 h the chest was opened under deep anesthesia. 
The whole body was then perfused with about 250 ml of warm sa-
line solution (37   °   C) infused into the left ventricle to wash the EB 
dye out of the circulation.
 After decapitation of the animal, the brain was divided into 
right and left hemispheres. Each hemisphere was weighed and ho-
mogenized in 2.5 ml of phosphate-buffered saline. The homoge-
nized solution was mixed with 2.5 ml of trichloroacetic acid (60%) 
and centrifuged for 30 min at 3,500 rpm (1,640  g ). The collected 
supernatant was used to determine the EB absorbance at 610 nm 
by a spectrophotometer (UV 1800; Shimadzu, Kyoto, Japan). EB 
concentrations were calculated against a standard curve and the 
obtained results are expressed as micrograms per gram of brain 
tissue.
 Assessment of Oxidative Stress Biomarkers 
 The animals were reperfused for 24 h, after which they were 
decapitated and the brain was removed. The ischemic area of the 
lesion in the hemisphere was separated according to well-estab-
lished protocols in rodent models  [16, 17] . The tissue was weighed 
and homogenized in PBS with a weight-to-volume ratio of 1: 5. The 
homogenate was centrifuged (10,000  g , 4   °   C) for 30 min. The su-
pernatant was used for quantifying the oxidative stress biomark-
ers. Lipid peroxidation was evaluated by determining the concen-
tration of MDA in the brain samples using the previously de-
scribed high-performance liquid chromatography (HPLC) method 
 [14, 18, 19] . Results are expressed as tissue WW (nmol/mg). The 
concentration of reduced GSH as an important index of antioxi-
dant defense capacity was also detected by the HPLC method  [14, 
18, 20] . Results are expressed as millimoles per milligram (mmol/
mg) of wet tissue weight.
 Statistical Analyses 
 The data are represented as the mean ± SEM and the signifi-
cance of differences were evaluated using one-way analysis of vari-
ance (ANOVA) followed by Tukey’s test. Statistical significance 
was accepted at p < 0.05.
 Results 
 Recording of Cerebral Blood Flow and Physiological 
Parameters  
 The baseline rCBF values recorded before MCAO 
were defined as 100%. The rCBF values were reduced to 
less than 20% of baseline in both the control and treated 
ischemic groups after MCA occlusion. There was no sig-
nificant difference between rCBF values in the groups 
during occlusion and the first 10 min of reperfusion 
( fig. 1 ). The physiological parameters measured were sys-
tolic blood pressure, heart rate, peripheral oxygen satura-
tion (SpO 2 ), and body temperature before and after 
MCAO, which were within the normal physiological 
range, and inter- and intragroup comparisons indicated 
no significant differences among them.
 Evaluation of the NDS and Infarct Size 
 Ischemia produced severe motor disabilities in control 
ischemic rats (4 ± 0.5). However, the NDS of ischemic rats 
treated with α-tocopherol was 1.75 ± 0.25 and the differ-
ence was statistically significant compared to the control 
group (p < 0.05). Sham-operated rats had no infarctions. 
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 Fig. 1. rCBF in control ischemic rats re-
ceived vehicle (n = 8) and ischemic rats re-
ceived α-tocopherol at a dose of 30 mg/kg 
(n = 8) before MCAO, during MCAO and 
during reperfusion times.  
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MCA occlusion of the left side of the brain produced con-
siderable cerebral lesions in the control-ischemia rats 
(422 ± 41 mm 3 ). Treatment with α-tocopherol (30 mg/kg) 
significantly diminished cerebral lesion volumes by 42.9% 
(241 ± 29 mm 3 , p < 0.01;  fig. 2 ).
 Assessment of Ischemic Brain Edema 
 There was no statistically significant difference be-
tween the water content of the right side of brains be-
tween the experimental groups (79.1 ± 0.28, 79.2 ± 0.34 
and 78.5 ± 0.17% for the sham, control and α-tocopherol-
treated groups, respectively). Water content of the left 
side of the brain in the control ischemic rats was signifi-
cantly more than that of the sham-operated rats (p < 
0.001, 83.8 ± 0.11 vs. 79 ± 0.2%, respectively). Post-
ischemic treatment with α-tocopherol (30 mg/kg) was 
significantly associated with lower brain water content 
(80.1 ± 0.32%) than that of control ischemic rats (p < 
0.001;  fig. 3 ). 
 Evaluation of BBB Permeability  
 There was no statistically significant difference be-
tween the EB concentrations of the right side of brains 
between the groups (0.87 ± 0.22, 1.88 ± 0.29 and 1.74 ± 
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 Fig. 2.  a Representative brain slices stained with TTC in the studied 
groups. Ischemic regions are white and nonischemic regions are 
red (colors refer to the online version only).  b Infarct size in the 
study groups. Values are means ± SEM (n = 8). + p < 0.001 versus 
sham group;  *  p < 0.01 versus control group.  
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 Fig. 3. Water content in the left and right sides of the brains in the 
study groups (n = 8).  +  p < 0.001 compared with the sham group; 
 *  p < 0.001 compared with the control group. 
 Fig. 4. EB concentration in the left and right sides of the brains in 
the study groups (n = 8).  +   p < 0.001 compared with the sham 
group;  *  p < 0.001 compared with the control group.  
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0.37 μg/g for the sham, control and α-tocopherol-treated 
groups, respectively). For the left side of the brain, the EB 
concentration of control ischemic rats was significantly 
more than that of sham-operated rats (p < 0.001, 14.58 ± 
1.29 vs. 1.1±.22 μg/g, respectively). Postischemic treat-
ment with α-tocopherol significantly lowered the EB con-
centration of the ischemic side of the brain (p < 0.001, 
6.66 ± 0.87 μg/g;  fig. 4 , 5).
 Assessment of MDA and GSH  
 The induction of ischemia and reperfusion in the con-
trol ischemic group resulted in significantly increased 
MDA concentrations (63.57 ± 5.42 nmol/mg) and re-
duced GSH concentrations (5.86 ± 0.31 mmol/mg) in the 
left side of the brain tissues, as compared to the sham 
group (p < 0.001). Treatment with α-tocopherol provided 
a significantly reduced MDA concentration (p < 0.001, 
26.84 ± 4.79 nmol/mg) and elevated GSH concentration 
(p < 0.01, 10.17 ± 0.83 mmol/mg) compared to the con-
trol ischemic group ( table 1 ). 
 Discussion 
 This study showed that treatment with α-tocopherol 
had protective effects against vasogenic edema forma-
tion based on reducing brain water content and EB leak-
age. This protective effect might be partly related to the 
inhibition of oxidative stress. As far as the literature is 
concerned, there is no report about the effects of 
α-tocopherol on edema formation and BBB destruction 
during ischemia. Stoffel et al.  [21] reported that dietary 
supplementation of α-tocopherol did not produce any 
significant influence against posttraumatic vasogenic 
brain edema. This dissimilarity in results might be re-
lated to differences in pathophysiological mechanisms 
involved in traumatic or ischemic brain edema and the 
diverse methods used. However, our findings confirmed 
previous studies that had reported the neuroprotective 
effects for α-tocopherol against ischemic brain damage 
 [9, 10] . It was demonstrated that vitamin E deficiency 
caused a greater neurological deficit and infarct volume 
 [22] while exogenous administration of α- tocopherol 
reduced ischemic reperfusion-induced neuronal dam-
age  [9] .
 Oxidative stress caused by the excessive production of 
free radicals and overwhelming of brain antioxidant ca-
pacity has been shown to be involved in ischemic brain 
damage  [23] . Compared to other tissues, the brain is more 
sensitive to oxidative damage because it has a high rate of 
metabolism, high lipid content and relative low protective 
antioxidant systems  [8, 24] . Our findings demonstrated 
that treatment with α-tocopherol produced protective ef-
fects against oxidative damage of the brain. This protec-
tion was partly achieved by a reduction of lipid peroxida-
tion and augmentation of brain antioxidant capacity via 
increased GSH. Previous studies showed that exogenous 
a b c
 Table 1.  Concentrations of reduced GSH and MDA in the study 
groups
Group GSH, mmol/mg MDA, nmol/mg
Sham 17.5 ± 1.17 17.12 ± 1.48
Control 5.86 ± 0.31+ 63.57 ± 5.42+
α-Tocopherol 10.17 ± 0.83* 26.84 ± 4.79**
 Values are the mean ± SEM (n = 8). + p < 0.001 versus sham;
* p < 0.01, **p < 0.001 versus control.
 Fig. 5. Photographs of brains in the sham ( a ), control ischemic ( b ) and α-tocopherol-treated (30 mg/kg;  c )
ischemic rats. The intensity of the blue color depicted in  b and  c (indicated by arrows; color refers to the online 
version only) is related to the extent of damage of the cerebral vasculature of the lesioned side. 
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administration of α-tocopherol attenuated raised levels of 
MDA after brain ischemia  [9, 25] . Additionally, it was re-
ported that α-tocopherol acts as an acyl-peroxyl-radical 
scavenger and inhibits superoxide anion production by 
leukocytes via reducing NADPH oxidase activity  [26] . 
Thus, protective effects of α-tocopherol against ischemic 
brain injury might be partly attributed to antioxidant ac-
tions. Beside the protective effects of α-tocopherol against 
lipid peroxidation are its nonantioxidant properties, such 
as the preservation of endothelial integrity, inhibition of 
monocyte-endothelial adhesion, reduction of cytokine re-
lease and platelet aggregation  [27–29] . In general, the in-
hibition of ROS formation, inflammation and apoptosis 
 [9, 10] could be possible mechanisms. However, further 
studies are needed to clarify the exact mechanisms of ben-
eficial α-tocopherol effects. 
 Conclusion 
 In this study, postischemic treatment with α-tocopherol 
attenuated vasogenic brain edema by protecting BBB in-
tegrity. In addition, the administration of α-tocopherol 
amplified the brain antioxidant capacity. These data sug-
gest that treatment with α-tocopherol provided protec-
tive effects against ischemic edema formation, partly by 
antioxidant actions.
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